Skip to main content
. Author manuscript; available in PMC: 2011 May 30.
Published in final edited form as: Front Endocrinol (Lausanne). 2011 Mar 3;2(6):00006. doi: 10.3389/fendo.2011.00006

Figure 3.

Figure 3

Well-by-well IP stimulation in response to a GnRH agonist, following rescue of mutant E90K by maximum, EC80 or no pharmacoperone (In3). Data is graphed by row, then column. The upper graphic shows the absence of tetracycline; the lower graphic shows the presence of tetracycline. Note that the Y-axis differs.